1. Home
  2. SNY
  3. SNY News

Latest Sanofi ADS (SNY) News on October 8, 2025

Sanofi (ENXTPA:SAN): Assessing Valuation After a 10% Weekly Share Price Recovery
SNY

Simply Wall St.

17 hours ago

Sanofi (ENXTPA:SAN): Assessing Valuation After a 10% Weekly Share Price Recovery

SNY

MT Newswires

18 hours ago

Novavax Completes Transfer of Marketing Authorization for COVID-19 Vaccine in EU to Sanofi

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment
SNY

PR Newswire

19 hours ago

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Health Care Roundup: Market Talk
SNY

The Wall Street Journal

a day ago

Health Care Roundup: Market Talk

Neurocrine Biosciences Appoints Mike Sibley as Senior Vice President, General Manager of Neuropsychiatry Franchise
SNY

PR Newswire

a day ago

Neurocrine Biosciences Appoints Mike Sibley as Senior Vice President, General Manager of Neuropsychiatry Franchise

Bullous Pemphigoid Market Analysis and Forecast Report 2025-2035
SNY

GlobeNewswire

2 days ago

Bullous Pemphigoid Market Analysis and Forecast Report 2025-2035

Aqemia to Participate in Jefferies European Disruptive Tech Conference
SNY

Business Wire

2 days ago

Aqemia to Participate in Jefferies European Disruptive Tech Conference

Sanofi (SNY) Invests $625 Million in Sanofi Ventures
SNY

Insider Monkey

3 days ago

Sanofi (SNY) Invests $625 Million in Sanofi Ventures

Novavax (NVAX) Is Up 10.6% After Sanofi Expands Matrix-M Licensing Agreement - Has the Bull Case Changed?
SNY

Simply Wall St.

4 days ago

Novavax (NVAX) Is Up 10.6% After Sanofi Expands Matrix-M Licensing Agreement - Has the Bull Case Changed?

SNY

Argus Research

6 days ago

Analyst Report: Regeneron Phars, Inc

SNY

MT Newswires

6 days ago

Revvity Launches Program to Expand Type 1 Diabetes Diagnosis Offering

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes
SNY

Business Wire

6 days ago

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

Sanofi (SNY) Caps Cost of Any Insulin Product at $35 per Month; Berenberg Reaffirms Its Buy Rating
SNY

Insider Monkey

6 days ago

Sanofi (SNY) Caps Cost of Any Insulin Product at $35 per Month; Berenberg Reaffirms Its Buy Rating

Pfizer Stock, Other Drugmakers Rally Again
SNY

The Wall Street Journal

6 days ago

Pfizer Stock, Other Drugmakers Rally Again

SNY

MT Newswires

7 days ago

European Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading

Kymera Overcomes Sanofi Deal Update, Marches Ahead With Pipeline
SNY

Zacks

7 days ago

Kymera Overcomes Sanofi Deal Update, Marches Ahead With Pipeline

2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi
SNY

GlobeNewswire

7 days ago

2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi

QuantHealth Secures Strategic Investment from Sanofi Ventures to Accelerate AI-Driven Clinical Trials
SNY

Business Wire

7 days ago

QuantHealth Secures Strategic Investment from Sanofi Ventures to Accelerate AI-Driven Clinical Trials

Health Care Roundup: Market Talk
SNY

The Wall Street Journal

7 days ago

Health Care Roundup: Market Talk

SNY

MT Newswires

7 days ago

Drugmaker Stocks Rise Pre-Bell as Pfizer, Trump Announce Price Cut Deal

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site
SNY

The Wall Street Journal

7 days ago

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

SNY

MT Newswires

8 days ago

Update: Market Chatter: Sanofi Reportedly Raided by EU Antitrust Regulators

SNY

MT Newswires

8 days ago

Market Chatter: Sanofi Reportedly Raided by EU Antitrust Regulators

SNY

MT Newswires

8 days ago

Novavax Expands Sanofi Collaboration to Cover Matrix-M in Flu Vaccine Program

Novavax Announces Progress on Sanofi Agreement
SNY

PR Newswire

8 days ago

Novavax Announces Progress on Sanofi Agreement

GSK Leaps Into Buy Zone On Surprise Departure Of CEO Emma Walmsley
SNY

Investor's Business Daily

8 days ago

GSK Leaps Into Buy Zone On Surprise Departure Of CEO Emma Walmsley

Bank of America Securities Maintains Buy on Sanofi (SNY)
SNY

Insider Monkey

9 days ago

Bank of America Securities Maintains Buy on Sanofi (SNY)

Assessing Sanofi’s Share Price After 7% Drop and Latest FDA Approval News
SNY

Simply Wall St.

10 days ago

Assessing Sanofi’s Share Price After 7% Drop and Latest FDA Approval News

SNY

MT Newswires

12 days ago

Sanofi to Offer its Insulins for $35 a Month in US Starting Jan. 1, 2026

Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US
SNY

PR Newswire

12 days ago

Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US

Trump’s overnight demand for 100% tariffs on pharmaceuticals will be ‘a meaningful commercial hit for U.S. consumers,’ top analyst says
SNY

Fortune

12 days ago

Trump’s overnight demand for 100% tariffs on pharmaceuticals will be ‘a meaningful commercial hit for U.S. consumers,’ top analyst says

Anemia Treatment Market Analysis by Disease Type, Therapy Class, Route of Administration, Countries and Competitive Landscape 2025-2033
SNY

GlobeNewswire

12 days ago

Anemia Treatment Market Analysis by Disease Type, Therapy Class, Route of Administration, Countries and Competitive Landscape 2025-2033

RIGL vs. FOLD: Which Biotech Stock Offers Better Growth Potential?
SNY

Zacks

13 days ago

RIGL vs. FOLD: Which Biotech Stock Offers Better Growth Potential?

SNY

MT Newswires

13 days ago

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Data Deluge

Sanofi announces $625m to venture capital arm
SNY

Pharmaceutical Technology

13 days ago

Sanofi announces $625m to venture capital arm

SNY

MT Newswires

13 days ago

Immuneering Prices $175 Million Stock Offering

Immuneering Announces Pricing of $175 Million Underwritten Public Offering of Class A Common Stock and Concurrent $25 Million Private Placement of Class A Common Stock to Sanofi
SNY

GlobeNewswire

13 days ago

Immuneering Announces Pricing of $175 Million Underwritten Public Offering of Class A Common Stock and Concurrent $25 Million Private Placement of Class A Common Stock to Sanofi

SNY

MT Newswires

13 days ago

Immuneering Posts Positive Pancreatic Cancer Data

SNY

MT Newswires

13 days ago

Sector Update: Health Care Stocks Decline Late Afternoon

Immuneering Announces Proposed Underwritten Public Offering of Class A Common Stock and Pre-Funded Warrants and Proposed Concurrent Private Placement of Class A Common Stock and Class B Common Stock to Sanofi
SNY

GlobeNewswire

13 days ago

Immuneering Announces Proposed Underwritten Public Offering of Class A Common Stock and Pre-Funded Warrants and Proposed Concurrent Private Placement of Class A Common Stock and Class B Common Stock to Sanofi

SNY

MT Newswires

14 days ago

Sector Update: Health Care Stocks Softer Wednesday Afternoon

Sanofi Ventures banks $625M to back young biotechs, digital health startups
SNY

BioPharma Dive

14 days ago

Sanofi Ventures banks $625M to back young biotechs, digital health startups

Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
SNY

GlobeNewswire

14 days ago

Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation

SNY

GlobeNewswire

14 days ago

Press release: Availability of the Q3 2025 Aide mémoire

FDA clears under-the-skin Keytruda; MBX shares double on study data
SNY

BioPharma Dive

15 days ago

FDA clears under-the-skin Keytruda; MBX shares double on study data

Press Release: Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1
SNY

GlobeNewswire

15 days ago

Press Release: Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1

FDA Delays Key Sanofi Multiple Sclerosis Drug Decision
SNY

Benzinga

16 days ago

FDA Delays Key Sanofi Multiple Sclerosis Drug Decision

SNY & REGN's Dupixent Receives CHMP Backing for Urticaria in EU
SNY

Zacks

16 days ago

SNY & REGN's Dupixent Receives CHMP Backing for Urticaria in EU

FDA Extends Review Period of Sanofi's Multiple Sclerosis Drug Filing
SNY

Zacks

16 days ago

FDA Extends Review Period of Sanofi's Multiple Sclerosis Drug Filing

Sanofi (ENXTPA:SAN): Exploring Valuation After Recent Share Price Drift, With No Major News Events
SNY

Simply Wall St.

16 days ago

Sanofi (ENXTPA:SAN): Exploring Valuation After Recent Share Price Drift, With No Major News Events

SNY

MT Newswires

16 days ago

Sanofi Says FDA Extends Target Action Date of Tolebrutinib Application Review by 3 Months

SNY

MT Newswires

16 days ago

Sanofi, Regeneron Say Potential Chronic Spontaneous Urticaria Treatment Recommended for EU Approval

Press Release: Update on the US regulatory review of tolebrutinib in non-relapsing, secondary progressive multiple sclerosis
SNY

GlobeNewswire

16 days ago

Press Release: Update on the US regulatory review of tolebrutinib in non-relapsing, secondary progressive multiple sclerosis

Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion
SNY

GlobeNewswire

16 days ago

Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion

Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with Positive CHMP Opinion
SNY

GlobeNewswire

16 days ago

Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with Positive CHMP Opinion

SNY

CNW Group

20 days ago

BMO Launches Additional Canadian Depositary Receipts (CDRs), Expanding Its Line-up to Include Heineken, Sanofi and AXA

Innate Pharma SA (IPHA) (H1 2025) Earnings Call Highlights: Strategic Focus and Financial ...
SNY

GuruFocus.com

20 days ago

Innate Pharma SA (IPHA) (H1 2025) Earnings Call Highlights: Strategic Focus and Financial ...

Regeneron Pharmaceuticals (REGN) Advances Allergy Pipeline with Two Positive Phase 3 Trials Evaluating First-in-Class Antibody-Blockers of Cat and Birch Allergies
SNY

Insider Monkey

20 days ago

Regeneron Pharmaceuticals (REGN) Advances Allergy Pipeline with Two Positive Phase 3 Trials Evaluating First-in-Class Antibody-Blockers of Cat and Birch Allergies

Lysosomal Storage Disease Treatment Market Analysis Report 2025-2034: Breakthroughs in Enzyme & Gene Therapies, Early Diagnosis Drive Demand
SNY

GlobeNewswire

21 days ago

Lysosomal Storage Disease Treatment Market Analysis Report 2025-2034: Breakthroughs in Enzyme & Gene Therapies, Early Diagnosis Drive Demand

Sanofi (SNY) Fell on Tariff Uncertainty
SNY

Insider Monkey

21 days ago

Sanofi (SNY) Fell on Tariff Uncertainty

EADV 25: Sanofi’s brivekimig success in Phase IIa HS trial
SNY

Clinical Trials Arena

21 days ago

EADV 25: Sanofi’s brivekimig success in Phase IIa HS trial

SNY

Investing.com

21 days ago

AstraZeneca says Fasenra misses main goal in COPD trial

Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study
SNY

GlobeNewswire

21 days ago

Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study

SNY

Investing.com

22 days ago

Kymera initiated at Outperform on potential of lead skin drug

AllRock Bio Announces $50 Million Series A to Advance Lead Clinical Program for Pulmonary Hypertension
SNY

PR Newswire

22 days ago

AllRock Bio Announces $50 Million Series A to Advance Lead Clinical Program for Pulmonary Hypertension

Senhwa Biosciences' CX-5461 Teams Up with Global PD-1 Leaders to Enter the Immunotherapy Arena, Targeting Multi-Billion Dollar Global Market
SNY

PR Newswire

22 days ago

Senhwa Biosciences' CX-5461 Teams Up with Global PD-1 Leaders to Enter the Immunotherapy Arena, Targeting Multi-Billion Dollar Global Market

Former CinCor execs reunite to helm new biotech startup
SNY

BioPharma Dive

22 days ago

Former CinCor execs reunite to helm new biotech startup

Leerink Partners Maintains a Buy Rating on Sanofi (SNY)
SNY

Insider Monkey

23 days ago

Leerink Partners Maintains a Buy Rating on Sanofi (SNY)

Sanofi: Information concerning the total number of voting rights and shares - August 2025
SNY

GlobeNewswire

a month ago

Sanofi: Information concerning the total number of voting rights and shares - August 2025

Novartis Catches a ‘Sell.’ Goldman Sachs Says the Stock Is Overvalued.
SNY

Barrons.com

a month ago

Novartis Catches a ‘Sell.’ Goldman Sachs Says the Stock Is Overvalued.

LB Pharmaceuticals tops 2025 biotech IPO list with $285m Nasdaq debut
SNY

Pharmaceutical Technology

a month ago

LB Pharmaceuticals tops 2025 biotech IPO list with $285m Nasdaq debut

GTCR to acquire generic drug maker Zentiva
SNY

Pharmaceutical Technology

a month ago

GTCR to acquire generic drug maker Zentiva

Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl
SNY

Barrons.com

a month ago

Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl

AMERICAN SKIN ASSOCIATION ANNUAL GALA CELEBRATES OUTSTANDING HONOREES
SNY

PR Newswire

a month ago

AMERICAN SKIN ASSOCIATION ANNUAL GALA CELEBRATES OUTSTANDING HONOREES

SNY's Gene Therapy Candidate for Eye Disease Gets FDA Fast Track Tag
SNY

Zacks

a month ago

SNY's Gene Therapy Candidate for Eye Disease Gets FDA Fast Track Tag

Sanofi’s Tzield gains approval in China for T1D management
SNY

Pharmaceutical Technology

a month ago

Sanofi’s Tzield gains approval in China for T1D management

SNY

MT Newswires

a month ago

Sanofi Says FDA Granted Fast-Track Designation for Age-Related Macular Degeneration Therapeutic Candidate

Press Release: Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration
SNY

GlobeNewswire

a month ago

Press Release: Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration

Private equity GTCR strikes $4.8 billion deal to buy Zentiva, FT reports
SNY

Reuters

a month ago

Private equity GTCR strikes $4.8 billion deal to buy Zentiva, FT reports

Mandy Moore and Celebrity Mom Squad join Sanofi to help protect babies from RSV with BEYFORTUS®
SNY

PR Newswire

a month ago

Mandy Moore and Celebrity Mom Squad join Sanofi to help protect babies from RSV with BEYFORTUS®

Press Release: Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes
SNY

GlobeNewswire

a month ago

Press Release: Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes

Lucem Health announces new initiative to accelerate early detection of Type 1 Diabetes (T1D)
SNY

PR Newswire

a month ago

Lucem Health announces new initiative to accelerate early detection of Type 1 Diabetes (T1D)

Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies
SNY

Business Wire

a month ago

Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies

Concussions Market Research Report 2025-2035 | Epidemiological Analysis, Key Market Trends, Patent Analysis, Regulatory Landscape, Pipeline Analysis, Market Dynamics
SNY

GlobeNewswire

a month ago

Concussions Market Research Report 2025-2035 | Epidemiological Analysis, Key Market Trends, Patent Analysis, Regulatory Landscape, Pipeline Analysis, Market Dynamics

Health Care Roundup: Market Talk
SNY

The Wall Street Journal

a month ago

Health Care Roundup: Market Talk

Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz™ (rilzabrutinib)
SNY

GlobeNewswire

a month ago

Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz™ (rilzabrutinib)

Why Dianthus Therapeutics, Up 47% In Four Weeks, Just Surged Again
SNY

Investor's Business Daily

a month ago

Why Dianthus Therapeutics, Up 47% In Four Weeks, Just Surged Again

SNY

Business Wire

a month ago

WPIX-TV to Carry New York Mets Games Through 2028

SNY

Argus Research

a month ago

Weekly Stock List

SNY

MT Newswires

a month ago

Morgan Stanley Upgrades Sanofi to Overweight From Equalweight, Price Target is $58

A Look at Sanofi (ENXTPA:SAN) Valuation Following FDA Approval of Breakthrough Rare Disease Therapy
SNY

Simply Wall St.

a month ago

A Look at Sanofi (ENXTPA:SAN) Valuation Following FDA Approval of Breakthrough Rare Disease Therapy

Sanofi (SNY) Loses 9% as New Drug Candidate Appears Weaker Than Predecessor
SNY

Insider Monkey

a month ago

Sanofi (SNY) Loses 9% as New Drug Candidate Appears Weaker Than Predecessor

Why Nektar Therapeutics Rippled Higher This Week
SNY

Motley Fool

a month ago

Why Nektar Therapeutics Rippled Higher This Week

Health Care Roundup: Market Talk
SNY

The Wall Street Journal

a month ago

Health Care Roundup: Market Talk

Acetaminophen Market Trends and Forecasts, 2023-2024 & 2025-2033 | Rising OTC Demand, Wider Access to Essential Medicines, and Growth in Combination Therapies Drive Expansion
SNY

GlobeNewswire

a month ago

Acetaminophen Market Trends and Forecasts, 2023-2024 & 2025-2033 | Rising OTC Demand, Wider Access to Essential Medicines, and Growth in Combination Therapies Drive Expansion

Lyophilized Injectable Drugs Market Report 2025-2033 | R&D Efforts to Improve Safety and Reconstitution Time, Alongside Expanding CDMO Services and Emerging Market Contributions
SNY

GlobeNewswire

a month ago

Lyophilized Injectable Drugs Market Report 2025-2033 | R&D Efforts to Improve Safety and Reconstitution Time, Alongside Expanding CDMO Services and Emerging Market Contributions

Revolut hires former SocGen boss Oudea as West Europe chairman
SNY

Reuters

a month ago

Revolut hires former SocGen boss Oudea as West Europe chairman

Today's moving stocks: American Eagle, Figma, T. Rowe Price, Amazon, Sanofi
SNY

TheStreet

a month ago

Today's moving stocks: American Eagle, Figma, T. Rowe Price, Amazon, Sanofi

Sanofi Drops As Eczema Drug Faces Big Test
SNY

GuruFocus.com

a month ago

Sanofi Drops As Eczema Drug Faces Big Test

SNY

MT Newswires

a month ago

Sector Update: Health Care Stocks Rise Late Afternoon

Share on Social Networks: